SmartMetric (SMME) 10-Q 13 Feb 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Dec. 31, 2018	Feb. 02, 2019
Document And Entity Information
Entity Registrant Name	SmartMetric, Inc.
Entity Central Index Key	1,301,991
Document Type	10-Q
Trading Symbol	SMME
Document Period End Date	Dec. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		256,676,745
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,019

Consolidated Balance Sheets (un

Consolidated Balance Sheets (unaudited) - USD ($)	Dec. 31, 2018	Jun. 30, 2018
Current assets:
Cash	$ 5,073	$ 4,427
Receivables	10,400	10,400
Prepaid expenses and other current assets	4,017	8,767
Total current assets	19,490	23,594
Total assets	19,490	23,594
Current liabilities:
Accounts payable and accrued expenses	769,323	730,794
Liability for stock to be issued	86,850	103,718
Deferred Officer salary	758,348	663,348
Related party interest payable	65,876	40,055
Credit card payable	1,313
Shareholder loan	18,520	15,000
Total current liabilities	1,700,230	1,552,915
Stockholders' deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Common stock, $.001 par value; 300,000,000 shares authorized, 256,676,745 and 249,147,547 shares issued and outstanding, respectively	256,677	249,148
Additional paid-in capital	24,479,000	24,217,831
Accumulated deficit	(26,417,027)	(25,996,910)
Total stockholders' deficit	(1,680,740)	(1,529,321)
Total liabilities and stockholders' deficit	$ 19,490	$ 23,594

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Preferred stock, authorized	5,000,000	5,000,000	5,000,000
Preferred stock, issued	610,000	610,000	610,000
Preferred stock, outstanding	610,000	610,000	610,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Common stock, authorized	300,000,000	300,000,000	300,000,000
Common stock, issued	256,676,745	256,676,745	249,147,547
Common stock, outstanding	256,676,745	256,676,745	249,147,547

Consolidated Statements Of Oper

Consolidated Statements Of Operations (unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Revenues
Expenses:
Officer's salary	47,500	47,500	95,000	95,000
Other general and administrative	124,157	177,358	248,161	352,557
Research and development	21,775	24,832	51,135	41,432
Total operating expenses	193,432	249,690	394,296	488,989
Loss from operations before income taxes	(193,432)	(249,690)	(394,296)	(488,989)
Interest expense	(13,358)	(10,580)	(25,820)	(20,238)
Income taxes
Net loss	$ (206,790)	$ (260,270)	$ (420,116)	$ (509,227)
Net loss per share, basic and diluted (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted (in shares)	254,804,287	236,963,268	252,521,874	234,893,779

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows (unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (260,270)	$ (509,227)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock and warrants issued and issuable for services
Asset impairment
Changes in assets and liabilities
Decrease in prepaid expenses and other current assets	4,750	39,190
(Decrease) increase in accounts payable and accrued expenses	38,529	19,294
Increase in deferred officer's salary	95,000	95,000
Increase (decrease) in credit card debt	1,313
Increase in accrued interest payable	25,821	20,238
Net cash used in operating activities	(94,857)	(335,505)
CASH FLOWS FROM INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties	3,520	(4,800)
Proceeds from sale of common stock	251,829	373,987
Net cash provided by financing activities	255,349	369,187
NET (DECREASE) IN CASH	160,492	33,682
CASH BEGINNING OF PERIOD	4,427	51,695
CASH END OF PERIOD	164,919	85,377
CASH PAID DURING THE PERIOD FOR:
Interest
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Issuance of preferred stock and reduction of additional paid in capital for patent
Conversion of Series B Convertible Preferred Stock to Common Stock

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	6 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (“SmartMetric” or the “Company”) was incorporated pursuant to the laws of Nevada on December 18, 2002. SmartMetric is a company engaged in the technology industry. SmartMetric’s main products are a fingerprint sensor activated payments card and a security card with a finger sensor and fully functional fingerprint reader embedded inside the card. The SmartMetric biometric cards have a rechargeable battery allowing for portable biometric identification and card activation. This card is referred to as a biometric card or the SmartMetric Biometric Card. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management of the Company, the accompanying unaudited financial statements contain all the adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the six months ended December 31, 2018 are not necessarily indicative of the results that may be expected for the year ending June 30, 2019. For further information, refer to the financial statements and the footnotes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2018, as filed with the Securities and Exchange Commission on October 12, 2018. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $420,116 and $509,227 for the six months ended December 31, 2018 and 2017 respectively, and has an accumulated deficit of $26,417,027 at December 31, 2018. There is no guarantee that the Company will be able to continue to raise enough capital or generate revenues to sustain its operations. There is no guarantee regarding the Company’s ability to continue as a going concern. Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The condensed consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates. Cash and Cash Equivalents Cash equivalents are comprised of certain highly liquid investments with maturity of three months or less when purchased. We maintain our cash in bank deposit accounts which, at times, may exceed federally insured limits. We have not experienced any losses in such accounts. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Revenue Recognition The Company has not recognized revenues to date. The Company anticipates recognizing revenue in accordance with the contracts it enters into for the sale and distribution of its products. Accounts Receivable The Company will extend credit based on its evaluation of the customers’ financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company will monitor exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The Company has not recorded any receivables, and therefore no allowance for doubtful accounts. Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of December 31, 2018 no accrual for uncertain income tax positions is necessary. The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2014. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed. Advertising Costs The Company will expense the cost associated with advertising as incurred. Equipment Equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated economic useful lives of the assets ranging from 3 - 5 years. Loss Per Share of Common Stock Basic net loss per common share is computed using the weighted average number of common shares outstanding. The calculation of diluted earnings per share (“EPS”) includes consideration of dilution arising from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants. Common stock equivalents were not included in the computation of diluted earnings per share on the consolidated statement of operations due to the fact that the Company reported a net loss and to do so would be anti-dilutive for the periods presented. Stock-Based Compensation The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital.

PREPAID EXPENSES

PREPAID EXPENSES	6 Months Ended
	Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses represent the unexpired terms of various consulting agreements as well as advance rental payments. The Company issued common stock and warrants as consideration for consulting services and these shares were valued based on the stock price or computed warrant value at the time of the respective agreements.

COMMITMENTS

COMMITMENTS	6 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 4 - COMMITMENTS Lease Agreement The Company’s main office is located in Las Vegas, Nevada. Rent expense under all leases for the six months ended December 31, 2018 and 2017 was $7,277 and $15,938 respectively. Related Party Transactions The Company’s Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $18,520 and $15,000 at December 31, 2018 and June 30, 2018, respectively. These advances bear interest at the rate of five percent (5%) per annum. The Company has accrued the amounts of $758,348 and $663,348 at December 31, 2018 and June 30, 2018, respectively, as deferred officer’s salary, for the difference between the Chief Executive Officer’s annual salary and the amounts paid. On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)	6 Months Ended
	Dec. 31, 2018
Equity [Abstract]
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 5 STOCKHOLDERS’ EQUITY (DEFICIT) Preferred Stock As of December 31, 2018, the Company has 5,000,000 shares of preferred stock, par value $0.001, authorized and 610,000 shares issued and outstanding. On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 shares of preferred stock as Series B Convertible Preferred Stock (“Series B Convertible Preferred Stock”). Effective November 5, 2014, the number of shares designated as Series B Convertible Preferred Stock was increased to 1,000,000 shares. Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 (“Stated Value”). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. Class A Common Stock As of December 31, 2018, the Company has 50,000,000 shares of Class A common stock, par value $0.001, authorized and no shares issued and outstanding. In October 2003, the Company issued 50,000,000 shares of Class A common stock at par value ($50,000). These shares were converted into 50,000,000 shares of common stock in 2006. Common Stock The Company was incorporated on December 18, 2002, with 45,000,000 shares of Common Stock, par value $0.001, authorized. The Articles of Incorporation were amended in 2006 to increase the number of authorized shares to 100,000,000 shares, and in 2009 to increase the number of authorized shares to 200,000,000. As a result of a screener’s error, the Company previously disclosed in its Quarterly Report on Form 10-Q for the quarters ended September 30, 2015 and December 31, 2015 that it increased the number of authorized shares of common stock to 300,000,000. On March 31, 2016, our Board of Directors approved an amendment (the “Amendment”) to the Company’s Articles of Incorporation to increase the total number of shares of authorized capital stock to 305,000,000 shares, par value $0.001 per share, consisting of (i) 300,000,000 shares of Common Stock, up from 200,000,000 shares of Common Stock, and (ii) 5,000,000 shares of Preferred Stock, subject to shareholder approval (the “Proposal”). On March 31, 2016, a majority of the Company’s stockholders approved the Amendment. The Company filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission on May 4, 2016 (the “Information Statement”). The Information Statement was furnished to all of the Company’s shareholders for the purpose of informing them of the action taken by a majority of the Company’s stockholders. As of December 31, 2018, the Company has 256,676,745 shares of common stock issued and outstanding. ● On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares. ● During the three months ended September 30, 2017, the Company sold for cash 2,500,000 shares of common stock and warrants to purchase: (i) 937,500 shares at $0.70 per share, (ii) 500,000 shares at $0.20 per share, (iii) 472,500 shares at $1.00 per share and (iv) 252,000 shares at $0.50 per share for net proceeds of $114,625. The warrants expire at various times through September 28, 2019 ● During the three months ended September 30, 2017, the Company issued 362,864 shares of common stock for consulting services valued at $21,825, based on the stock price at the time of the respective agreements underlying the services provided. ● During the three months ended December 31, 2017, the Company sold for cash 8,319,000 shares of common stock and warrants to purchase: (i) 3,250,000 shares at $0.20 per share and (ii) 1,638,000 shares at $0.50 per share, for net proceeds of $259,362. The warrants expire at various times through December 29, 2019 During the three months ended December 31, 2017, the Company issued 212,164 shares of common stock for consulting services valued at $15,000, based on the stock price at the time of the respective agreements underlying the services provided. ● During the three months ended March 31, 2018, the Company sold for cash 2,850,000 shares of common stock and warrants to purchase: (i) 2,051,250 shares at $0.70 per share and (ii) 929,250 shares at $1.00 per share, for net proceeds of $142,305. The warrants expire at various times through February 21, 2020. During the three months ended March 31, 2018, the Company issued 508,620 shares of common stock for consulting services valued at $30,000, based on the stock price at the time of the respective agreements underlying the services provided. ● During the three months ended June 30, 2018, the Company sold for cash 2,646,100 shares of common stock and warrants to purchase: (i) 1,536,625 shares at $0.70 per share and (ii) 774,459 shares at $1.00 per share, for net proceeds of $119,738. The warrants expire at various times through June 15, 2020. ● During the three months ended September 30, 2018, the Company sold for cash 4,624,153 shares of common stock for net proceeds of $145,770 and warrants to purchase (i) 3,699,988 shares at $0.25, (ii) 60,000 shares at $0.30, (iii) 30,000 shares at $0.50, (iv) 301,875 shares at $0.70 and (v) 151,970 shares at $1.00. ● During the three months ended December 31, 2018, the Company sold for cash 5,212,499 shares of common stock and warrants to purchase: (i) 3,712,499 shares at $0.25 per share and (ii) 1,500,000 shares at $0.50 per share, for net proceeds of $106,060. The warrants expire at various times through December 4, 2020. Warrants From time to time the Company granted warrants in connection with private placements of securities, as described herein. As of December 31, 2018, and June 30, 2018, the following is a breakdown of the warrant activity: December 31, 2018: Outstanding - June 30, 2018 14,842,583 Issued 9,456,572 Exercised — Expired (4,042,000 ) Outstanding - December 31, 2018 20,257,155 June 30, 2018: Outstanding - June 30, 2017 20,276,399 Issued 12,341,584 Exercised — Expired (17,775,400 ) Outstanding - June 30, 2018 14,842,583 At December 31, 2018, all of the 20,257,155 warrants are vested and (i) 27,555,665 warrants expire at various times prior to December 4, 2020, (ii) 3,000,000 warrants expire in September 2019, (iii) and 300,000 warrants expire in July 2020.

INCOME TAXES

INCOME TAXES	6 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 6 INCOME TAXES The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year. Cumulative adjustments to the Company’s estimate are recorded in the interim period in which a change in the estimated annual effective rate is determined. The Company has estimated its effective tax rate to be 0%, based primarily on losses incurred and the uncertainty of realization of the tax benefit of such losses.

LITIGATION

LITIGATION	6 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 7 LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 SUBSEQUENT EVENTS There were no subsequent events at the time of filing.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents are comprised of certain highly liquid investments with maturity of three months or less when purchased. We maintain our cash in bank deposit accounts which, at times, may exceed federally insured limits. We have not experienced any losses in such accounts.
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.
Revenue Recognition	Revenue Recognition The Company has not recognized revenues to date. The Company anticipates recognizing revenue in accordance with the contracts it enters into for the sale and distribution of its products.
Accounts Receivable	Accounts Receivable The Company will extend credit based on its evaluation of the customers’ financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company will monitor exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The Company has not recorded any receivables, and therefore no allowance for doubtful accounts.
Uncertainty in Income Taxes	Uncertainty in Income Taxes GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of December 31, 2018 no accrual for uncertain income tax positions is necessary. The Company files income tax returns in the United States (“U.S.”) federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2014. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed.
Advertising Costs	Advertising Costs The Company will expense the cost associated with advertising as incurred.
Equipment	Equipment Equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated economic useful lives of the assets ranging from 3 - 5 years.
Loss Per Share of Common Stock	Loss Per Share of Common Stock Basic net loss per common share is computed using the weighted average number of common shares outstanding. The calculation of diluted earnings per share (“EPS”) includes consideration of dilution arising from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants. Common stock equivalents were not included in the computation of diluted earnings per share on the consolidated statement of operations due to the fact that the Company reported a net loss and to do so would be anti-dilutive for the periods presented.
Stock-Based Compensation	Stock-Based Compensation The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital.

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	6 Months Ended
	Dec. 31, 2018
Stockholders' Equity Note [Abstract]
Schedule of share based compensation warrant activity	As of December 31, 2018, and June 30, 2018, the following is a breakdown of the warrant activity: December 31, 2018: Outstanding - June 30, 2018 14,842,583 Issued 9,456,572 Exercised — Expired (4,042,000 ) Outstanding - December 31, 2018 20,257,155 June 30, 2018: Outstanding - June 30, 2017 20,276,399 Issued 12,341,584 Exercised — Expired (17,775,400 ) Outstanding - June 30, 2018 14,842,583

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (206,790)	$ (260,270)	$ (420,116)	$ (509,227)
Accumulated deficit	$ (26,417,027)		$ (26,417,027)		$ (25,996,910)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	6 Months Ended
	Dec. 31, 2018
Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	5 years

COMMITMENTS (Details Narrative)

COMMITMENTS (Details Narrative) - USD ($)	Sep. 11, 2017	Dec. 31, 2018	Dec. 31, 2017	Mar. 31, 2018	Jun. 30, 2018
Rent expense		$ 7,277	$ 15,938
Deferred compensation liability		758,348			$ 663,348
Chaya Hendrick [Member]
Cash advances from related party		$ 18,520			$ 15,000
Interest rate				5.00%
Series B Convertible Preferred Stock [Member] | Chaya Hendrick [Member]
Description of Preferred Stock	On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

STOCKHOLDERS' EQUITY (DEFICIT_2

STOCKHOLDERS' EQUITY (DEFICIT) (Details) - Warrant [Member] - shares	6 Months Ended	12 Months Ended
	Dec. 31, 2018	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding - beginning of year	14,842,583	20,276,399
Issued	9,456,572	12,341,584
Exercised
Expired	(4,042,000)	(17,775,400)
Outstanding - end of year	20,257,155	14,842,583

STOCKHOLDERS' EQUITY (DEFICIT_3

STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) - USD ($)	Sep. 11, 2017	Nov. 05, 2014	Oct. 31, 2003	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2009	Dec. 11, 2009	Jun. 30, 2006	Dec. 18, 2002
Preferred Stock, Authorized				5,000,000	5,000,000	5,000,000				5,000,000
Preferred stock, par value (in dollars per share)				$ 0.001	$ 0.001	$ 0.001				$ 0.001
Preferred stock, shares issued				610,000	610,000	610,000				610,000
Preferred stock, outstanding				610,000	610,000	610,000				610,000
Number of shares issued				5,212,499	4,624,153	2,646,100	2,850,000	8,319,000	2,500,000
Common stock, shares authorized				300,000,000	300,000,000	300,000,000				300,000,000
Common stock, par value (in dollars per share)				$ 0.001	$ 0.001	$ 0.001				$ 0.001
Common stock, shares issued				256,676,745	256,676,745	249,147,547				256,676,745
Common stock, shares outstanding				256,676,745	256,676,745	249,147,547				256,676,745
Proceeds from sale of common stock				$ 106,060	$ 145,770	$ 119,738	$ 142,305	$ 259,362		$ 251,829	$ 373,987
Warrant expiration date				Dec. 4, 2020		Jun. 15, 2020	Feb. 21, 2020	Dec. 29, 2019	Sep. 28, 2019
Warrant [Member]
Number of warrant vested				20,257,155	20,257,155	14,842,583				20,257,155		20,276,399
Warrant One [Member]
Number of securities				3,712,499		1,536,625	2,051,250	3,250,000	937,500	3,712,499	3,250,000
Exercise price of warrants				$ .25		$ 0.70	$ 0.70	$ 0.20	$ 0.70	$ .25	$ 0.20
Warrant Two [Member]
Number of securities				1,500,000	3,699,988	774,459	929,250	1,638,000	500,000	1,500,000	1,638,000
Exercise price of warrants				$ .50	$ 0.25	$ 1	$ 1	$ 0.50	$ 0.20	$ .50	$ 0.50
Warrant Three [Member]
Number of securities					60,000				472,500
Exercise price of warrants					$ 0.30				$ 1
Warrant Four [Member]
Number of securities					30,000				252,000
Exercise price of warrants					$ 0.50				$ 0.50
Warrant Expired On December 4, 2020 [Member]
Number of warrants expired										27,555,665
Warrant Expired Through September 2019 [Member]
Number of warrants expired										3,000,000
Warrant Expired On July 2020 [Member]
Number of warrants expired										300,000
Warrant Five [Member]
Number of securities					301,875
Exercise price of warrants					$ 0.70
Warrant Six [Member]
Number of securities					151,970
Exercise price of warrants					$ 1
Consultant [Member]
Number of shares issued for services							508,620	212,164	362,864
Common stock issued for services							$ 30,000	$ 15,000	$ 21,825
Series B Convertible Preferred Stock [Member]
Preferred Stock, Authorized		1,000,000														500,000
Preferred stock, par value (in dollars per share)		$ 0.001														$ 0.001
Preferred stock, Stated Value Per Share		$ 5														$ 5
Description of conversion of stock		Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock.
Series B Convertible Preferred Stock [Member] | Chaya Hendrick [Member]
Description of Preferred Stock	On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.
Common Stock [Member]
Common stock, shares authorized													305,000,000	300,000,000	200,000,000		100,000,000	45,000,000
Common stock, par value (in dollars per share)													$ 0.001					$ 0.001
Common Class [Member]
Description of conversion of stock			These shares were converted into 50,000,000 shares of common stock in 2006.
Common stock, shares authorized					50,000,000
Common stock, par value (in dollars per share)			$ 50,000		$ 0.001
Common stock, shares issued			50,000,000

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	6 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Effective tax rate	0.00%